Skip to main content

Closed

PTCT: PTC Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Operating margin11.5%

ROIC0.7%

Financially safe

Stretched

Debt / equity-2.19×

Interest coverage-11.9×

Current ratio2.44×

PTC Therapeutics, Inc.

PTCTNASDAQ Global Select·USD·Closed

PTC Therapeutics, Inc.

PTCTNASDAQ·USD·Closed

$68.01

−9.94%

$68.01

−$7.51 (9.94%)

52W Range

52thpctl

Volume

2.42×avg

Mkt Cap

5.64BUSD

P/E

-137.7TTM

Div Yield

–ann

52W Range

52thpctl

Volume

2.42×avg

Market Cap

5.64BUSD

P/E Ratio

-137.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings